Amphotericin B: time for a new "gold standard". (Q44527998)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12884167%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Amphotericin B: time for a new "gold standard" (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12884167%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12884167%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Luis L Ostrosky-Zeichner

series ordinal

1

object named as

Luis Ostrosky-Zeichner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12884167%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

2

Kieren A Marr

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12884167%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Stuart H Cohen

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12884167%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

22 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12884167%20AND%20SRC:MED&resulttype=core&format=json

Clinical Infectious Diseases

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12884167%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12884167%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12884167%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

415-425

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12884167%20AND%20SRC:MED&resulttype=core&format=json

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

6 November 2019

cites work

1 reference

Cryptococcus neoformans var. gattii--evidence for a natural habitat related to decaying wood in a pottery tree hollow

21 January 2018

1 reference

Lipid-based antifungal agents: current status

21 January 2018

1 reference

Pulmonary mycetoma due to Candida albicans: case report and review

21 January 2018

1 reference

Need for Alternative Trial Designs and Evaluation Strategies for Therapeutic Studies of Invasive Mycoses

21 January 2018

1 reference

Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B.

21 January 2018

1 reference

Efficacy of escalating doses of liposomal amphotericin B (AmBisome) against hematogenous Candida lusitaniae and Candida krusei infection in neutropenic mice

21 January 2018

1 reference

Amphotericin B lipid complex therapy of experimental fungal infections in mice

21 January 2018

1 reference

Dose-dependent pharmacokinetics of amphotericin B lipid complex in rabbits

21 January 2018

1 reference

Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection.

21 January 2018

1 reference

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

21 January 2018

1 reference

Clinical use of liposomal and lipid-complexed amphotericin B.

21 January 2018

1 reference

Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents

21 January 2018

1 reference

AmBisome (liposomal amphotericin B): a comparative review.

21 January 2018

1 reference

Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats

21 January 2018

1 reference

Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system

21 January 2018

1 reference

Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model

21 January 2018

1 reference

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

21 January 2018

1 reference

Amphotericin B lipid complex in pediatric patients with invasive fungal infections

21 January 2018

1 reference

The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses

21 January 2018

1 reference

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

21 January 2018

1 reference

Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia

21 January 2018

1 reference

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group

21 January 2018

1 reference

An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis.

21 January 2018

1 reference

Amphotericin B-induced nephrotoxicity: a review

21 January 2018

1 reference

Mortality and costs of acute renal failure associated with amphotericin B therapy

21 January 2018

1 reference

Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis

21 January 2018

1 reference

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients

21 January 2018

1 reference

Fungal infections in cancer patients: an international autopsy survey.

21 January 2018

1 reference

Intrathecal amphotericin in the management of coccidioidal meningitis

21 January 2018

1 reference

Management of neonatal candidiasis. Neonatal Candidiasis Study Group

21 January 2018

1 reference

Correlates of acute renal failure in patients receiving parenteral amphotericin B.

21 January 2018

1 reference

Amphotericin B--not so terrible

21 January 2018

1 reference

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America

21 January 2018

1 reference

Practice guidelines for lipid-based amphotericin B in stem cell transplant recipients

21 January 2018

1 reference

Reduced nephrotoxicity of conventional amphotericin B therapy after minimal nephroprotective measures: animal experiments and clinical study

21 January 2018

1 reference